Dr. Sarah Jeurissen, Oncologie SRL
Dr. Sarah Jeurissen, Oncologie reported total assets of 127,073 € at the end of the 2025 financial year (annual accounts filed with the NBB on 13 Apr 2026).
The score of Dr. Sarah Jeurissen, Oncologie shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -38 % Total assets +397 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. Sarah Jeurissen, Oncologie's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 13 Apr 2026
- Year ended 31 Dec 2024filed on 03 Jun 2025
- Year ended 31 Dec 2023filed on 09 Jun 2024
- Year ended 31 Dec 2022filed on 08 Jun 2023
Dr. Sarah Jeurissen, Oncologie's financial analysis
- Solvency7.4%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. Sarah Jeurissen, Oncologie
Dr. Sarah Jeurissen, Oncologie's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0768.493.881
- VAT number
- No VAT activity declared to the CBE
- Peppol
- Registered · 0208:0768493881 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 May 2021
- Registered office
- 9550 Herzele
- Latest accounts
- 2025 · filed on 13 Apr 2026
- Activity
- Medical specialists activities (NACE 86220)
Dr. Sarah Jeurissen, Oncologie (SRL) has been based in Herzele since 2021, active in: medical specialists activities. For 2025, it reports a net profit of 27,728 € and equity of 9,367 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. Sarah Jeurissen, Oncologie
Companies in the same business, of comparable size and area, outside its group.
Frequently asked questions about Dr. Sarah Jeurissen, Oncologie
What is the revenue of Dr. Sarah Jeurissen, Oncologie?
Dr. Sarah Jeurissen, Oncologie files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. Sarah Jeurissen, Oncologie?
According to the Crossroads Bank for Enterprises, no VAT-liable activity is declared for Dr. Sarah Jeurissen, Oncologie. If it is VAT-registered, its VAT number is its company number prefixed with BE: BE0768493881. Its company number (CBE) is 0768.493.881.
Where is the registered office of Dr. Sarah Jeurissen, Oncologie?
According to the CBE register, the registered office of Dr. Sarah Jeurissen, Oncologie is in 9550 Herzele.
What is the equity of Dr. Sarah Jeurissen, Oncologie?
At the close of the 2025 financial year, the equity of Dr. Sarah Jeurissen, Oncologie amounts to 9,367 €, a solvency of 7.4% of total assets.
Who manages Dr. Sarah Jeurissen, Oncologie?
The register lists 1 active mandates at Dr. Sarah Jeurissen, Oncologie. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dr. Sarah Jeurissen, Oncologie
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →